{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:36:56Z","timestamp":1776724616381,"version":"3.51.2"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.pbb.2021.173112","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T21:35:20Z","timestamp":1610487320000},"page":"173112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Reinforcing effects of synthetic cathinones in rhesus monkeys: Dose-response and behavioral economic analyses"],"prefix":"10.1016","volume":"202","author":[{"given":"Fernando B.","family":"de Moura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Sherwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Prisinzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Paronis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Kohut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pbb.2021.173112_bb5000","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/adb.12038","article-title":"Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats","volume":"18","author":"Aarde","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pbb.2021.173112_bb0005","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00213-015-3944-8","article-title":"In vivo potency and efficacy of the novel cathinone \u03b1-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats","volume":"232","author":"Aarde","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2021.173112_bb0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/adb.12201","article-title":"Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects","volume":"21","author":"Anizan","year":"2016","journal-title":"Addict Biol"},{"key":"10.1016\/j.pbb.2021.173112_bb0015","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","article-title":"The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue","volume":"37","author":"Baumann","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2021.173112_bb0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0022-3565(25)20689-9","article-title":"Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys","volume":"251","author":"Bergman","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2021.173112_bb0025","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/0024-3205(90)90178-T","article-title":"Behavioral economics of drug self-admnistration. I. Functional equivalence of response requirement and drug dose","volume":"47","author":"Bickel","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2021.173112_bb0030","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/adb.12069","article-title":"Acquisition of MDMA self-administration: pharmacokinetic factors and MDMA-indueced serotonin release","volume":"19","author":"Bradbury","year":"2014","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pbb.2021.173112_bb0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/hup.2296","article-title":"Presence and composition of cathinone derivatives in drug samples taken from a drug test service in Spain (2010\u22122012)","volume":"28","author":"Caudevilla-G\u00e1lligo","year":"2013","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pbb.2021.173112_bb0040","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1007\/s00213-019-05339-4","article-title":"Self-administration of synthetic cathinones 3,4-methlenedioxypyrovalerone (MDPV) and \u03b1-pyrrolidiniopentiophenone (\u03b1-PVP) in rhesus monkeys","volume":"236","author":"Collins","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2021.173112_bb0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuropharm.2015.01.003","article-title":"Intravenous self-administration of mephedrone, methylone and MDMA in females rats","volume":"92","author":"Creehan","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2021.173112_bb0050","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/qjmed\/hcq056","article-title":"Purchasing \u2018legal highs\u2019 on the internet\u2014is there consistency in what you get?","volume":"103","author":"Davies","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.pbb.2021.173112_bb0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuropharm.2018.01.020","article-title":"\u201cEcstasy\u201d to addiction: mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA","volume":"133","author":"Dolan","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2021.173112_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/jpet.116.236349","article-title":"Structure-activity relationships of substituted cathinones, with transporter binding, uptake, and release","volume":"360","author":"Eshleman","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2021.173112_bb0065","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","article-title":"Substituted methcathinones differ in transporter and receptor interactions","volume":"85","author":"Eshleman","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2021.173112_bb0070","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/npp.2012.233","article-title":"In vivo effects of abused \u201cbath salt\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity","volume":"38","author":"Fantegrossi","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2021.173112_bb0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0376-6357(96)00051-4","article-title":"Demand curves for food in hens: similarity under fixed-ratio and progressive-ratio schedules","volume":"39","author":"Foster","year":"1997","journal-title":"Behav. Process."},{"key":"10.1016\/j.pbb.2021.173112_bb0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.116.239376","article-title":"Individual differences in the relative reinforcing effects of 3,4-methylenedioxypyrovalerone under fixed and progressive ratio schedules of reinforcement in rats","volume":"361","author":"Gannon","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2021.173112_bb0085","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/FBP.0000000000000315","article-title":"Reinforcing effects of abused \u201cbath salts\u201d constituents 3,4-methylenedioxypyrovalerone and \u03b1-pyrrolidinopentiophenone and their enantiomers","volume":"28","author":"Gannon","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2021.173112_bb0090","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/s41386-018-0209-3","article-title":"The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter","volume":"43","author":"Gannon","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2021.173112_bb0095","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/npp.2017.141","article-title":"Reinforcing effects of binary mixtures of common bath salt constituents: studies with 3,4-methylenedioxypyrovalerone (MDPV), 3,4-methylenedioxymethcathinone (methylone), and caffeine in rats","volume":"43","author":"Gannon","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2021.173112_bb0100","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00213-018-5046-x","article-title":"Behavioral economic analysis of the reinforcing effects of \u201cbath salts\u201d mixtures: studies with MDPV, methylone, and caffeine in male Sprague-Dawley rats","volume":"236","author":"Gannon","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2021.173112_bb0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.lfs.2013.07.023","article-title":"Bath salts and synthetic cathinones: an emerging designer drug phenomenon","volume":"97","author":"German","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2021.173112_bb0110","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/00001756-199704140-00006","article-title":"Phentermine\/fenfluramine decreases cocaine self-administration in rhesus monkeys","volume":"8","author":"Glowa","year":"1997","journal-title":"NeuroReport"},{"key":"10.1016\/j.pbb.2021.173112_bb0115","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/bph.12951","article-title":"Stereochemistry of mephedrone neuropharmacology: enatiomer-specific behavioural and neurochemical effects in rats","volume":"172","author":"Gregg","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2021.173112_bb0120","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/FBP.0000000000000328","article-title":"Effects of D1 and D2 receptor antagonists on the discriminative stimulus effects of methylendioxypyrovalerone and mephedrone in male Sprague-Dawley rats trained to discriminate D-amphetamine","volume":"28","author":"Harvey","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2021.173112_bb0125","article-title":"Manganese-enhanced magnetic resonance imaging reveals differential long-term neuroadaptation after methamphetamine and the substituted cathinone 4-methylmethcathinone (mephedrone)","volume":"18","author":"den Hollander","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2021.173112_bb0130","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1037\/0033-295X.115.1.186","article-title":"Economic demand and essential value","volume":"155","author":"Hursh","year":"2008","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.pbb.2021.173112_bb0135","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1901\/jeab.1988.50-419","article-title":"A cost-benefit analysis of demand for food","volume":"50","author":"Hursh","year":"1988","journal-title":"J. Exp. Anal. Behav."},{"key":"10.1016\/j.pbb.2021.173112_bb0140","first-page":"589","article-title":"Self-administration and behavioral economics of second-generation synthetic cathinones in male rats","volume":"234","author":"Huskinson","year":"2017"},{"key":"10.1016\/j.pbb.2021.173112_bb0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1901\/jeab.2006.102-04","article-title":"Replacing relative reinforcer efficacy with behavioral economic demand curves","volume":"85","author":"Johnson","year":"2006","journal-title":"J. Exp. Anal. Behav."},{"key":"10.1016\/j.pbb.2021.173112_bb0150","series-title":"Monitoring the Future National Survey Results on Drug Use 1975\u20132018: Overview, Key Findings on Adolescent Drug Use","author":"Johnston","year":"2019"},{"key":"10.1016\/j.pbb.2021.173112_bb0155","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1007\/s00213-016-4293-y","article-title":"Reinforcing effectiveness of nicotine nonhuman primates: effects of nicotine dose and history of nicotine self-administration","volume":"233","author":"Kohut","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2021.173112_bb0160","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.drugalcdep.2013.07.032","article-title":"Differential effects of acute and chronic treatment with the \u03b12-adrenergic agonist, lofexidine, on cocaine self-administration in rhesus monkeys","volume":"133","author":"Kohut","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2021.173112_bb0165","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1007\/s00213-017-4731-5","article-title":"Cocaine-like discriminative stimulus effects of \u201cnorepinephrine-preferring\u201d monoamine releasers: time course and interaction studies in rhesus monkeys","volume":"234","author":"Kohut","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2021.173112_bb0170","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1124\/jpet.103.049825","article-title":"The reinforcing efficacy of psychostimulants in rhesus monkeys: the role of pharmacokinetics and pharmacodynamics","volume":"307","author":"Lile","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2021.173112_bb0175","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1476-5381.2012.01998.x","article-title":"Comparative neuropharmacology of three psychostimulant cathinone derivates: butylone, mephedrone and methylone","volume":"167","author":"L\u00f3pez-Arnau","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2021.173112_bb0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00442246","article-title":"Effects of fixed ratio size and dose on phencyclidine self-administration by rats","volume":"97","author":"Marquis","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2021.173112_bb0185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","article-title":"Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalernone (MDPV)","volume":"87","author":"Marusich","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2021.173112_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2013.06.016","article-title":"Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports","volume":"132","author":"Miotto","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2021.173112_bb0195","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-3565(25)31050-5","article-title":"Ketamine self-administration by the rhesus monkey","volume":"203","author":"Moreton","year":"1977","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2021.173112_bb0200","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2006.11.075","article-title":"The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain","volume":"22","author":"Nagai","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2021.173112_bb0205","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.106.107383","article-title":"Monoamine releasers with varying selectivity for dopamine\/norepinephrine versus serotonin release as candidate \u201cagonist\u201d medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys","volume":"320","author":"Negus","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2021.173112_bb0210","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0022-3565(25)24116-7","article-title":"Relationship between self-administration of amphetamine and monoamine receptors in brain: comparisons with cocaine","volume":"248","author":"Ritz","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2021.173112_bb0215","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1126\/science.2820058","article-title":"Cocaine receptors on dopamine transporters are related to self-administration of cocaine","volume":"237","author":"Ritz","year":"1987","journal-title":"Science"},{"issue":"2\u20133","key":"10.1016\/j.pbb.2021.173112_bb5005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0278-5846(88)90040-1","article-title":"Cocaine self-administration appears to be mediated by dopamine uptake inhibition","volume":"12","author":"Ritz","year":"1988","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2021.173112_bb0220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","article-title":"Monoamine transporters and psychostimulant drugs","volume":"479","author":"Rothman","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2021.173112_bb0225","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1196\/annals.1369.064","article-title":"Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs","volume":"1074","author":"Rothman","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pbb.2021.173112_bb0230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00213-003-1407-0","article-title":"Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats","volume":"169","author":"Schenk","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2021.173112_bb0235","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1111\/j.1460-9568.2007.05932.x","article-title":"MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding","volume":"26","author":"Schenk","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2021.173112_bb0240","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3109\/15563650.2014.933231","article-title":"Comprehensive analysis of \u201cbath salts\u201d purchased from California stores and the internet","volume":"52","author":"Schneir","year":"2014","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.pbb.2021.173112_bb0245","first-page":"416","article-title":"Forensic investigation of K2, spice, and \u201cbath salt\u201d commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds","volume":"233","author":"Seely","year":"2013","journal-title":"For Sci Int"},{"key":"10.1016\/j.pbb.2021.173112_bb0250","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2021.173112_bb0260","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2125.2000.00121.x","article-title":"Non-linear pharmacokinetics of MDMA (\u2019ecstasy\u2019) in humans","volume":"49","author":"de la Torre","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pbb.2021.173112_bb0255","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/15563650.2011.590812","article-title":"Clinical experience with and analytical confirmation of \u201cbath salts\u201d and \u201clegal highs\u201d (synthetic cathinones in the United States)","volume":"49","author":"Spiller","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.pbb.2021.173112_bb0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuropharm.2004.07.019","article-title":"The addicted brain viewed in the light of imaging studies: brain circuits and treatment strategies","volume":"47","author":"Volkow","year":"2004","journal-title":"Neuropharmcology"},{"key":"10.1016\/j.pbb.2021.173112_bb0270","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00213-007-0858-0","article-title":"A behavioral economic analysis of cocaine and remifentanil self-administration in rhesus monkeys","volume":"194","author":"Wade-Galuska","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2021.173112_bb0275","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pbb.2006.05.022","article-title":"Self-administration of mixtures of fenfluramine and amphetamine by rhesus monkeys","volume":"84","author":"Wee","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2021.173112_bb0280","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1124\/jpet.104.080101","article-title":"Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs","volume":"313","author":"Wee","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2021.173112_bb0285","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1126\/science.185.4156.1067","article-title":"Fenfluramine: amphetamine congener that fails to maintain drug-taking behavior in the rhesus monkey","volume":"185","author":"Woods","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.pbb.2021.173112_bb0290","first-page":"149","article-title":"Determinants of cocaine self-administration by laboratory animals","volume":"166","author":"Woolverton","year":"1992","journal-title":"CIBA Found. Symp."},{"key":"10.1016\/j.pbb.2021.173112_bb0295","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/dta.1365","article-title":"Prevalence and co-existence of active components of \u2018legal highs\u2019","volume":"5","author":"Zuba","year":"2013","journal-title":"Drug Test Anal"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305721000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305721000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:38:27Z","timestamp":1758775107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305721000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":61,"alternative-id":["S0091305721000101"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2021.173112","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reinforcing effects of synthetic cathinones in rhesus monkeys: Dose-response and behavioral economic analyses","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2021.173112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173112"}}